Lipigon Pharmaceuticals AB (OSTO:LPGO) Days Sales Outstanding : 0.00 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Lipigon Pharmaceuticals AB Days Sales Outstanding?

Lipigon Pharmaceuticals AB's average Accounts Receivable for the three months ended in Dec. 2023 was kr0.36 Mil. Lipigon Pharmaceuticals AB's Revenue for the three months ended in Dec. 2023 was kr0.00 Mil.

The historical rank and industry rank for Lipigon Pharmaceuticals AB's Days Sales Outstanding or its related term are showing as below:

OSTO:LPGO' s Days Sales Outstanding Range Over the Past 10 Years
Min: 48.38 Med: 49.47 Max: 122.84
Current: 122.84

During the past 6 years, Lipigon Pharmaceuticals AB's highest Days Sales Outstanding was 122.84. The lowest was 48.38. And the median was 49.47.

OSTO:LPGO's Days Sales Outstanding is ranked worse than
73.24% of 893 companies
in the Biotechnology industry
Industry Median: 73.01 vs OSTO:LPGO: 122.84

Lipigon Pharmaceuticals AB's Days Sales Outstanding stayed the same from Sep. 2022 (0.00) to Dec. 2023 (0.00).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Lipigon Pharmaceuticals AB Days Sales Outstanding Historical Data

The historical data trend for Lipigon Pharmaceuticals AB's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lipigon Pharmaceuticals AB Days Sales Outstanding Chart

Lipigon Pharmaceuticals AB Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

78.53

48.38

49.47

Lipigon Pharmaceuticals AB Quarterly Data
	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial												-	-	91.56	2,103.86	-

Competitive Comparison of Lipigon Pharmaceuticals AB's Days Sales Outstanding

For the Biotechnology subindustry, Lipigon Pharmaceuticals AB's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lipigon Pharmaceuticals AB's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lipigon Pharmaceuticals AB's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Lipigon Pharmaceuticals AB's Days Sales Outstanding falls into.

Lipigon Pharmaceuticals AB Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Lipigon Pharmaceuticals AB's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	16.407	*	365
=	0					/	16.407	*	365
=	0.00

Lipigon Pharmaceuticals AB's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.357	+	0)	/	1 )	/	0	*	365 / 4
=	0.357					/	0	*	365 / 4
=	N/A

Lipigon Pharmaceuticals AB (OSTO:LPGO) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Lipigon Pharmaceuticals AB Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Lipigon Pharmaceuticals AB's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Lipigon Pharmaceuticals AB (OSTO:LPGO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lipigon Pharmaceuticals AB (OSTO:LPGO) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

9RP:Germany

Address

Tvistevagen 48 C, Umea, SWE, 90736

Website

https://www.lipigon.se

Lipigon Pharmaceuticals AB develops medicines for diseases caused by disorders of the body's handling of fats. It focuses on orphan drugs for unusual diseases where there is no adequate treatment.

Lipigon Pharmaceuticals AB (OSTO:LPGO) Headlines

No Headlines